These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4051120)

  • 1. Possible mechanism of the synergistic effect of heparin and dihydroergotamine.
    Kakkar VV; Welzel D; Murray WJ; Malone P; Jones D
    Am J Surg; 1985 Oct; 150(4A):33-8. PubMed ID: 4051120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action.
    Comerota AJ; Stewart GJ; White JV
    Am J Surg; 1985 Oct; 150(4A):39-44. PubMed ID: 3901791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postoperative changes in hemostasis by heparin/dihydroergotamine prevention].
    Briel RC
    Fortschr Med; 1983 May; 101(18):846-9. PubMed ID: 6862345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness-risk ratio of heparin-dihydroergotamine].
    Kakkar VV
    Dtsch Med Wochenschr; 1983 Oct; 108(40):1536-7. PubMed ID: 6617512
    [No Abstract]   [Full Text] [Related]  

  • 5. Dihydroergotamine-heparin to prevent postoperative deep vein thrombosis.
    Med Lett Drugs Ther; 1985 May; 27(688):45-6. PubMed ID: 3889570
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness and side effects of low-molecular weight heparin-dihydroergotamine in preventing thromboembolism in abdominal surgery].
    Voigt J; Hamelmann H; Hedderich J; Seifert J; Buchhammer T; Köhler A
    Zentralbl Chir; 1986; 111(21):1269-305. PubMed ID: 3544605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe vasospastic reactions (ergotism) during prophylactic administration of heparin-dihydroergotamine.
    Bounameaux H; Schneider PA; Mossaz A; Suter P; Vasey H
    Vasa; 1987; 16(4):370-2. PubMed ID: 3424957
    [No Abstract]   [Full Text] [Related]  

  • 8. [Arterial vasospasm as a complication of the prevention of thromboembolism with heparin-dihydroergotamine and its treatment].
    Schott G; Riedel K
    Zentralbl Chir; 1986; 111(21):1354-7. PubMed ID: 3101315
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of postoperative thromboembolisms in general surgery by the combination of heparin and dihydroergotamine.
    Sándor T; László E; Magyary F; Turcsányi G; Hetényi L; Izinger E
    Acta Chir Hung; 1986; 27(2):107-14. PubMed ID: 3529772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients.
    Urlep-Salinović V; Jelatancev B; Gorisek B
    Thromb Haemost; 1994 Jul; 72(1):16-20. PubMed ID: 7974365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination dihydroergotamine mesylate and heparin sodium with lidocaine HCl. Pharmacokinetics, mechanism of action, clinical efficacy, and adverse effects.
    Barone JA; Raia JJ; Levy DB
    Pharmacotherapy; 1986; 6(4 Pt 2):3S-11S. PubMed ID: 3534804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thromboembolic disease and changes in coagulation after total hip arthroplasty. Effect of prophylaxis with acetylsalicylic acid or heparin-dihydroergotamine].
    Alfaro M; Páramo JA; de Pablos J; Cañadell J; Rocha E
    Sangre (Barc); 1986; 31(2):145-55. PubMed ID: 3726711
    [No Abstract]   [Full Text] [Related]  

  • 13. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
    DiSerio FJ; Sasahara AA
    Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of thromboembolic disease and platelet-related changes following total hip replacement: a comparative study of aspirin and heparin-dihydroergotamine.
    Alfaro MJ; Páramo JA; Rocha E
    Thromb Haemost; 1986 Aug; 56(1):53-6. PubMed ID: 3535158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of heparin-dihydergot in the prevention of thromboembolic complications].
    Kuster B; Gruber UF
    Schweiz Med Wochenschr; 1984 Mar; 114(10):322-32. PubMed ID: 6369529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.
    Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S
    Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the prophylaxis of deep venous thrombosis: a profile of embolex. Proceedings of a scientific symposium. May 3, 1985, New York City.
    Pharmacotherapy; 1986; 6(4 Pt 2):1S-29S. PubMed ID: 3774564
    [No Abstract]   [Full Text] [Related]  

  • 18. [Postoperative thromboembolism prophylaxis with a reduced low dose heparin fraction and dihydroergotamine in fixed combination (author's transl)].
    Buttermann G; Haluszczynski I; Theisinger W; Pabst HW
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1213-6. PubMed ID: 6790966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine.
    Kakkar VV; Stamatakis JD; Bentley PG; Lawrence D; de Haas HA; Ward VP
    JAMA; 1979 Jan; 241(1):39-42. PubMed ID: 758493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in general surgery].
    Schott G
    Z Gesamte Inn Med; 1984 Sep; 39(17):431-5. PubMed ID: 6506818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.